TD Cowen Has Lowered Expectations for Acadia Healthcare (NASDAQ:ACHC) Stock Price

Acadia Healthcare (NASDAQ:ACHC) had its target price reduced by equities research analysts at TD Cowen from $70.00 to $66.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. TD Cowen’s price target points to a potential upside of 44.33% from the company’s previous close.

Several other brokerages have also recently commented on ACHC. Cantor Fitzgerald reiterated a “neutral” rating and issued a $52.00 price target on shares of Acadia Healthcare in a research note on Tuesday, December 10th. KeyCorp raised Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 price target for the company in a research note on Tuesday. Barclays decreased their price objective on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a report on Friday, November 22nd. Royal Bank of Canada decreased their target price on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a research report on Monday, November 18th. Finally, StockNews.com lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $70.22.

Acadia Healthcare Stock Performance

Shares of NASDAQ ACHC traded up $0.88 during midday trading on Tuesday, hitting $45.73. 923,573 shares of the company’s stock traded hands, compared to its average volume of 1,980,728. The firm has a fifty day moving average of $40.70 and a 200 day moving average of $58.54. Acadia Healthcare has a 1 year low of $36.50 and a 1 year high of $87.77. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The stock has a market capitalization of $4.25 billion, a price-to-earnings ratio of 14.99, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. The company had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. Acadia Healthcare’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period last year, the firm earned $0.91 EPS. On average, analysts forecast that Acadia Healthcare will post 3.38 earnings per share for the current year.

Institutional Investors Weigh In On Acadia Healthcare

Institutional investors have recently added to or reduced their stakes in the stock. Everence Capital Management Inc. purchased a new position in shares of Acadia Healthcare in the 4th quarter worth approximately $203,000. GAMMA Investing LLC boosted its stake in Acadia Healthcare by 259.6% in the fourth quarter. GAMMA Investing LLC now owns 2,384 shares of the company’s stock valued at $95,000 after acquiring an additional 1,721 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in Acadia Healthcare by 17.0% in the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock worth $198,258,000 after purchasing an additional 454,044 shares during the last quarter. Principal Financial Group Inc. increased its position in shares of Acadia Healthcare by 2.1% during the third quarter. Principal Financial Group Inc. now owns 656,889 shares of the company’s stock worth $41,653,000 after purchasing an additional 13,368 shares in the last quarter. Finally, Oddo BHF Asset Management Sas acquired a new stake in shares of Acadia Healthcare in the 3rd quarter worth $1,613,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.